WENA (Anew Medical, Inc.) Gross Margin

Official company branding of Anew Medical (WENA)

Anew Medical, Inc. (WENA) relies on a compact staff of scientists motivated by equity stakes. An efficient gross margin demonstrates the results of this strategy, where 0.00 is the current value of the indicator. The company is developing gene therapies to combat ALS and Alzheimer's disease, planning to monetize brain regeneration methods. Intellectual property protection provides a competitive advantage while FDA verdicts are pending.

WENA: anewmeds.com Return on Gross Profit 06/25/2024 - 09/17/2024

Analytical breakdowns and data insights for company Anew Medical (WENA)

Fundamental valuation:WENA, Anew Medical, Inc.
Mass-produced product of anewmeds.com

Gross margin determines the portion of revenue remaining after covering direct production costs, which characterizes the business's operational cushion. The trend in the gross margin rate allows for an assessment of cost management efficiency and the pace of solvency recovery. For Anew Medical, Inc. (WENA), this calculation is critical, as it reflects the profitability of developing Klotho protein therapy to combat neurodegeneration and ALS.

Key competitors

Return on Gross Profit Biogen Corp|Return on Gross Profit NBIX|Regencell Corp (RGC) - Return on Sales by Gross Profit|Gross Margin AXSM|Return on Gross Profit ACADIA Pharmaceuticals ACAD|Gross Margin XENE (Xenon Pharmaceuticals Inc.)|VKTX (Viking Therapeutics, Inc.) - Gross Profitability Margin|SUPN - Gross Profitability|Catalyst Pharmaceuticals Inc (CPRX) - Return on Gross Profit|DNLI (Denali Corp) - Return on Gross Profit|Gross Profit Margin harmonybiosciences.com (HRMY)|Return on Gross Profit BHVN|Gross Margin Amylyx|Gross Margin TRVI|PRAX (Praxis Corp) - Gross Profit Rate|Gross Margin AVXL (anavex.com)|CBLL: Gross Return on Sales|PRTA - Gross Profitability|ALEC - Gross Margin|Annexon Inc. (ANNX) - Gross Profitability|Return on Gross Profit Omeros Corp|Return on Gross Profit NGNE|ACIU: Gross Profit Rate|Return on Gross Profit VYGR (Voyager Corp)|Return on Gross Profit Neumora NMRA|Gross Profitability Scilex Holding Company, Inc. SCLX|Gross Sales Margin Tevogen Bio Inc.|ACOG - Gross Profitability|Gross Sales Margin Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Return on Gross Profit|Cassava Sciences Inc (SAVA) - Gross Margin|Return on Gross Profit ASRT|Gross Margin coyatherapeutics.com|Gross Margin VTGN|Ovid Therapeutics - Gross Return on Sales|Gross Margin ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Return on Gross Profit|ATHE - Gross Profitability|Return on Sales by Gross Profit clene.com CLNN|PEPG: Gross Margin|Gross Return on Sales JUNS|RLMD (Relmada Corp) - Gross Margin|Annovis Bio Inc (ANVS) - Return on Sales by Gross Profit|Gross Profitability Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Gross Profit Rate|Gross Profitability Klotho Neurosciences KLTO|NRSN: Gross Return on Sales|RVPH: Return on Gross Profit|MTVA: Gross Profitability|NRXS (NeurAxis Inc) - Return on Gross Profit|Return on Gross Profit Helius Medical Technologies, Inc.|Gross Profitability Passage Bio Inc.|Gross Profit Margin bionomics.com.au NEUP|Gross Margin NERV|Gross Margin Athira Pharma Inc (ATHA)|Gross Margin ADXN (Addex Therapeutics Ltd.)|ALZN: Gross Return on Sales|CYCN - Gross Profitability|Gross Profit Margin Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Return on Gross Profit|Gross Sales Margin Cortigent, Inc. CRGT|Gross Profitability Avenue Therapeutics, Inc.|Return on Gross Profit BrainStorm Cell Therapeutics Inc. (BCLI)|Gross Profitability Cara Therapeutics, Inc (CARA)|Gross Profitability CHRO (Chromocell Therapeutics Corp.)|Gross Margin ELYM (eliemtx.com)|intracellulartherapies.com - Gross Profitability|LBPH: Return on Gross Profit|Gross Profit Rate MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Return on Gross Profit|Return on Gross Profit NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Gross Margin|Neurotrope - Gross Profitability Margin|Gross Margin TRVN|Return on Sales by Gross Profit Vigil Neuroscience, Inc.|Gross Margin CERE (cerevel.com)